“Clinical and Peripheral Blood Markers Predict Relapsed Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant”. 2025. Graduate Medical Scholars Journal 1 (S1). http://gmscholars.com/index.php/gmsj/article/view/59.